who made semaglutide Focus: Demand for weight-loss drugs fuels global rise in counterfeits Henry Meds Semaglutide Review [2026]

Japan: Demand for GLP-1 receptor agonists in Japan is projected to rise at 6.4% CAGR through 2036

As for safety, Semaglutide is already FDA-approved and widely considered safe when used under medical supervision

Metformin and insulin For participants taking insulin or metformin, the 5-year breast cancer survival rate was 82.3%, and the 10-year survival rate was 76.4%, compared to 97.4% and 96%, respectively, in the GLP-1 group

SREBP-1 then promotes lipid synthesis by increasing fatty acid synthase in cancer cells and mediating transgelin-2 overexpression to increase PDAs ability to survival and proliferation (Sun et al., 2017